Literature DB >> 30836132

Risk of diabetic ketoacidosis during Ramadan fasting: A critical reappraisal.

Salem A Beshyah1, Tahseen A Chowdhury2, Nazim Ghouri3, Abdulfattah A Lakhdar4.   

Abstract

OBJECTIVES: To evaluate the validity of the perceived increased risk and the actual occurrence of DKA observed during fasting in Ramadan.
METHODS: This is a non-systematic narrative review of the literature on the occurrence of DKA during Ramadan. Online databases (PubMed, Google Scholar, Cochrane Database, Medline OVID and CINAHL EBSCO) were searched. Three research questions are addressed 1. What is the basis of the expert opinion on the risk for DKA? 2. What is the likelihood that DKA is precipitated by Ramadan fast? and 3. What is the frequency of observed DKA during Ramadan?
RESULTS: The expert opinion suggesting a risk of DKA during Ramadan fasting was proposed with no evidence in the early writing on Ramadan fasting and has been reiterated and propagated since then. However, from first principles, DKA is not readily precipitated by the usual stress-free metabolic environment induced by Ramadan fasting with the exception of cases involved in the usual risk factors for metabolic decompensation. Furthermore, recent studies could not document any increase in observed DKA during Ramadan fasting in retrospective, prospective and database studies.
CONCLUSIONS: The current state of knowledge and evidence suggests the risk of DKA is not increased during Ramadan fasting.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  DKA; Ethnicity, Muslims, Diabetic ketoacidosis; Fasting; Feasting, Hyperglycaemia; Hypoglycaemia; Infection; Ketosis; Ramadan

Mesh:

Year:  2019        PMID: 30836132     DOI: 10.1016/j.diabres.2019.02.027

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  6 in total

Review 1.  Ramadan and Diabetes: A Narrative Review and Practice Update.

Authors:  Syed H Ahmed; Tahseen A Chowdhury; Sufyan Hussain; Ateeq Syed; Ali Karamat; Ahmed Helmy; Salman Waqar; Samina Ali; Ammarah Dabhad; Susan T Seal; Anna Hodgkinson; Shazli Azmi; Nazim Ghouri
Journal:  Diabetes Ther       Date:  2020-09-09       Impact factor: 2.945

Review 2.  Recommendations for management of diabetes during Ramadan: update 2020, applying the principles of the ADA/EASD consensus.

Authors:  Mahmoud Ibrahim; Melanie J Davies; Ehtasham Ahmad; Firas A Annabi; Robert H Eckel; Ebtesam M Ba-Essa; Nuha Ali El Sayed; Amy Hess Fischl; Pamela Houeiss; Hinde Iraqi; Ines Khochtali; Kamlesh Khunti; Shabeen Naz Masood; Safia Mimouni-Zerguini; Samad Shera; Jaakko Tuomilehto; Guillermo E Umpierrez
Journal:  BMJ Open Diabetes Res Care       Date:  2020-05

3.  Experiences and views of people with diabetes during Ramadan fasting: A qualitative meta-synthesis.

Authors:  Jieying Liao; Tianfang Wang; Zhan Li; Haotian Xie; Shanshan Wang
Journal:  PLoS One       Date:  2020-11-23       Impact factor: 3.240

4.  Efficacy and safety of combination of empagliflozin and metformin with combination of sitagliptin and metformin during Ramadan: an observational study.

Authors:  Ibrar Ahmed; Umar Yousaf Raja; Muhammad Umar Wahab; Tejhmal Rehman; Osama Ishtiaq; A H Aamir; Tahir Ghaffar; Abbas Raza; Suresh Kumar; Akhtar Sherin; Faisal Masood; Fawad Ahmad Randhawa; Ali Asghar; Sehrish Khan
Journal:  BMC Endocr Disord       Date:  2022-10-13       Impact factor: 3.263

5.  Effect of Dosage Reduction of Hypoglycemic Multidrug Regimens on the Incidences of Acute Glycemic Complications in People With Type 2 Diabetes Who Fast During Ramaḍān: A Randomized Controlled Trial.

Authors:  Louay Y Zaghlol; Amir F Beirat; Justin Z Amarin; Amro M Hassoun Al Najar; Yazan Y Hasan; Abdallah Qtaishat; Michael E Tierney; Raja Y Zaghlol; Ayman A Zayed
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-07       Impact factor: 5.555

6.  Effect of Ramadan fasting in patients with type 2 diabetes mellitus treated with sodium-glucose cotransporter 2 inhibitors: A systematic review and meta-analysis.

Authors:  Hoda Gad; Noor Al-Nassr; Ibrahim Mohammed; Adnan Khan; Ross MacDonald; Paul Mussleman; Rayaz A Malik
Journal:  J Diabetes Investig       Date:  2022-01-13       Impact factor: 3.681

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.